Keyword: Harvard University
RootPath raised $7 million to develop a T-cell therapy platform for cancer treatment that addresses the shortcomings of current technology.
Recent biotech discoveries include a sensory protein at the heart of hearing and new insights into how CAR-T design affects cancer treatments.
A tool called “polygenic risk scoring” could help physicians identify who faces a high risk of serious diseases.
One of the founding scientists of Illumina has come out with a new gene-sequencing software startup that aims to tackle antimicrobial resistance.
New discoveries in biotech include a coated capsule for delivering insulin and inherited gene mutations that may portend pancreatic cancer risk.
Feng Zhang's latest CRISPR company, Beam Therapeutics, officially came out of stealth Monday with $87 million in series A funding.
The past week ushered in news of a drug that reverses the decline of intestinal stem cells, a CAR-T for colorectal cancer and more.
The Sino-American startup thinks it can detect cell-free DNA in blood plasma and thereby enable screening for early-stage disease.
Amgen joined with MP Healthcare Venture Management and Alexandria Venture Investments to put the latest tranche of funding into QurAlis.
Novartis foresees next-generation immunotherapies that use biodegradable implants and injectable systems to trigger long-lasting attacks on tumors.
